Live Breaking News & Updates on Brandon Folkes Cantor Fitzgerald

Stay updated with breaking news from Brandon folkes cantor fitzgerald. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Eagle Pharmaceuticals Inc (EGRX) Q4 2020 Earnings Call Transcript

Eagle Pharmaceuticals Inc (EGRX) Q4 2020 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Eagle Pharmaceuticals Inc (NASDAQ: EGRX)
Popular Searches
Operator
Good morning, everyone. My name is Leo and I ll be your conference operator. At this time, I d like to welcome everyone to Eagle Pharmaceuticals Fourth Quarter and Full-Year 2020 Financial Results and Pipeline Review Call. [Operator Instructions] After the speakers remarks, there will be a question-and-answer period. [Operator Instructions]
It is now my pleasure to turn the floor over to Ms. Lisa Wilson, Investor Relations for Eagle Pharmaceuticals. Please go ahead.
This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume a ....

United States , Lisam Wilson , Tim Lugo William Blair , Lisa Wilson , Randall Stanicky , Zachary Sachar Piper Jaffray , Piper Sandler , Brandon Folkes Cantor Fitzgerald , David Pernock , Brian Cahill , Tim Lugo , David Amsellem , Brandon Folkes , William Blair , Investor Relations For Eagle Pharmaceuticals , Development Agreement , Eagle Pharmaceuticals Inc , Research Laboratory , American Society Of Clinical Oncology , Motley Fool Eagle Pharmaceuticals Inc , Eagle Pharmaceuticals , Eagle Pharmaceuticals Fourth Quarter , Cantor Fitzgerald , Strategic National , Welcome To Eagle Pharmaceuticals , Call Transcript ,

MannKind Corporation (MNKD) Q4 2020 Earnings Call Transcript

MannKind Corporation (MNKD) Q4 2020 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
MannKind Corporation (NASDAQ: MNKD)
Operator
Good morning, and welcome to MannKind Corporation fourth-quarter and full-year 2020 earnings call. As a reminder, this call is being recorded on February 25, 2021, and will be available for playback on the MannKind Corporation website shortly after the conclusion of this call until March 11, 2021. This call will contain forward-looking statements. Such forward-looking statements are subject to risk and uncertainty, which could cause actual results to differ materially from these stated expectations.
For further information on the company s risk factors, please see their 10-K report filed with the Securities and Exchange Commission this morning, the earnings release and the slides prepared for this presentation. Joining us today for MannKind are ch ....

Oren Livnat , Steven Binder , Michael Castagna , Brandon Folkes Cantor Fitzgerald , Dylan Dupuis , Robert Hazlett , Steven Lichtman , Val Mann , Thomas Smith , Thomas Hofmann , Jen Lendon , Brandon Folkes , Motley Fool Mannkind Corporation , Exchange Commission , Mannkind Corporation , Cantor Fitzgerald , College Diabetes Network , Steven Lichtman Oppenheimer Co , Oren Livnat Hc Wainwright Co , Receptor Life Sciences , Call Transcript , Motley Fool Logo , Kind Corporation , Foolish Best , Motley Fool , Obligatory Capitalized Disclaimers ,

Cerus Corporation (CERS) Q4 2020 Earnings Call Transcript

Cerus Corporation (CERS) Q4 2020 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Cerus Corporation (NASDAQ: CERS)
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Cerus Corporation s Fourth Quarter and Full Year 2020 Financial Results Conference Call. [Operator Instructions] It is now my pleasure to introduce the Cerus management team. Please go ahead.
This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company s SEC filings. Please see our ....

United States , Hong Kong , Jacob Johnson , Williamm Greenman , Josh Jennings , Matthew Blackman , Asia Pac , Brandon Folkes Cantor Fitzgerald , Hemo Minas , Matthew Blackman Stifel , Vivek Jayaraman , Vivekk Jayaraman , Asia Pacific , Carol Moore , Brandon Folkes , Cerus Corporation Fourth Quarter , Stephens Inc , Regulatory Affairs , Cantor Fitzgerald , Cerus Corporation , Jacob Johnson Stephens Inc Analyst , Motley Fool Cerus Corporation , Call Transcript , Motley Fool Logo , Fourth Quarter , Full Year ,

Jazz Pharmaceuticals PLC (JAZZ) Q4 2020 Earnings Call Transcript

Jazz Pharmaceuticals PLC (JAZZ) Q4 2020 Earnings Call Transcript
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

Brucec Cozadd , Jason Gerberry , Kim Sablich , Anne Borgman , Annabel Samimy , Balaji Prasad , Sam Pearce , David Steinberg , Andrean Flynn , Piper Sandler , Gregg Gilbert , David Risinger Morgan Stanley , Rob Iannone , David Risinger , Randall Stanicky , Gary Nachman , Graig Suvannavejh , Brandon Folkes Cantor Fitzgerald , Balaji Prasad Barclays , Jessica Fye , Annabel Samimy Stifel , Dan Swisher , Shawn Mindus , Bruce Cozadd , Jessica Fye Jpmorgan , America Merrill Lynch ,

Emergent BioSolutions Inc (EBS) Q4 2020 Earnings Call Transcript

Emergent BioSolutions Inc (EBS) Q4 2020 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

United States , Bob Kramer , Bob Burrows , Syed Husain , Jacob Hughes , Brandon Folkes Cantor Fitzgerald , Brandon Folkes , Cantor Fitzgerald , Human Services , Emergent Biosolutions Inc , Strategic National , United States Strategic National , Emergent Biosolutions Fourth Quarter , Investor Relations , Chief Executive Officer , Rich Lindahl , Chief Financial Officer , Chief Executive , United States Strategic National Stockpile , Public Private , Providence Therapeutics , Manitoba Canada , Anthrax Vaccines , Anthrax Monoclonal Therapeutic , Narcan Nasal Spray , Vice President ,